» Articles » PMID: 30648314

The Chang Gung Research Database-A Multi-institutional Electronic Medical Records Database for Real-world Epidemiological Studies in Taiwan

Overview
Publisher Wiley
Date 2019 Jan 17
PMID 30648314
Citations 172
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The Chang Gung Research Database (CGRD), the largest multi-institutional electronic medical records (EMR) collection in Taiwan, provides good access for researchers to efficiently use the standardized patient-level data. This study evaluates the capacity and representativeness of the CGRD to promote secondary use of EMR data for clinical research with more accurate estimates.

Methods: The National Health Insurance Research Database (NHIRD) which covers over 99.9% of the Taiwanese population served as the comparator in this study. We compare the data components of the CGRD with the NHIRD, including records for health care facilities, patients, diagnoses, drugs, and procedures. Using the chi-square test, we compared the distributions of age categories and sex of patients, and the rates of their health conditions between NHIRD and CGRD based on the year 2015.

Results: The CGRD contains more clinical information such as pathological and laboratory results than the NHIRD. The CGRD includes 6.1% of outpatients and 10.2% of hospitalized patients from the NHIRD. We found the CGRD includes more elderly outpatients (23.5% vs 12.5%) and pediatric inpatients (19.7% vs 14.4%) compared with the NHIRD. We found patients' sex distributions were similar between CGRD and NHIRD, but coverage rates of severe conditions, such as cancer, were higher than other health conditions in CGRD.

Conclusions: The CGRD could serve as the basis for accurate estimates in medical studies. However, researchers should pay special attention to selection biases since patients' characteristics from CGRD differ from those of the national database.

Citing Articles

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease-mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1-3 chronic kidney disease.

Tsai D, Chuang A, Liu K, Shao S, Lai E CMAJ. 2025; 197(7):E178-E189.

PMID: 39993818 PMC: 11867598. DOI: 10.1503/cmaj.240922.


Dipeptidyl peptidase 4 inhibitors reduce the risk of adverse outcomes after acute kidney injury in diabetic patients.

Liao H, Cheng C, Chen H, Chen J, Pan H, Huang T Clin Kidney J. 2025; 18(2):sfae385.

PMID: 39927258 PMC: 11806628. DOI: 10.1093/ckj/sfae385.


Validation of insurance claims data on aetiology, surgical type and prosthesis for isolated valve surgery: a retrospective observational surgery.

Hou B, Huang J, Chen C, Chang F, Cheng Y, Wu V BMJ Open. 2025; 15(2):e084197.

PMID: 39922592 PMC: 11808885. DOI: 10.1136/bmjopen-2024-084197.


Glucagon-like peptide 1 receptor agonists outperform basal insulin in cardiovascular and renal outcomes for type 2 diabetes mellitus: a retrospective cohort study.

Chen T, Tseng C, Li Y, Lin Y, Chen D, Yang N Acta Diabetol. 2025; .

PMID: 39812791 DOI: 10.1007/s00592-024-02443-6.


Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study.

Huang Z, Liao T, Chuang A, Shao S, Lange J, Lin T Osteoporos Int. 2025; 36(3):465-473.

PMID: 39777487 PMC: 11882658. DOI: 10.1007/s00198-024-07381-1.